相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Antibiotic Drug Resistance Pattern of Uropathogens in Pediatric Patients in Pakistani Population
Zakia Iqbal et al.
ANTIBIOTICS-BASEL (2023)
In vitro activity of Ceftazidime-Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019
Yamuna Devi Bakthavatchalam et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2022)
NDM Production as a Dominant Feature in Carbapenem-Resistant Enterobacteriaceae Isolates from a Tertiary Care Hospital
Fakhur Uddin et al.
ANTIBIOTICS-BASEL (2022)
Impact of Acquired Broad-Spectrum β-Lactamases on Susceptibility to Cefiderocol and Newly Developed β-Lactam/β-Lactamase Inhibitor Combinations in Escherichia coli and Pseudomonas aeruginosa
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Antibiotic resistance in patients with urinary tract infections in Pakistan
M. Bullens et al.
PUBLIC HEALTH ACTION (2022)
Resistance to Some New Drugs and Prevalence of ESBL- and MBL-Producing Enterobacteriaceae Uropathogens Isolated from Diabetic Patients
Othman M. Alzahrani et al.
LIFE-BASEL (2022)
Phenotypic and genotypic distribution of ESBL, AmpC ,B-lactamase and carbapenemase-producing Enterobacteriaceae in community-acquired and hospital-acquired urinary tract infections in Sri Lanka
Pandithage Dona Vindya Madushika Perera et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2022)
OXA-48 Carbapenemase-Encoding Transferable Plasmids of Klebsiella pneumoniae Recovered from Egyptian Patients Suffering from Complicated Urinary Tract Infections
Ann A. Elshamy et al.
BIOLOGY-BASEL (2021)
Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study
George Abongomera et al.
BMC INFECTIOUS DISEASES (2021)
New β-Lactam-β-Lactamase Inhibitor Combinations (vol 34, e00115-20, 2021)
Dafna Yahav et al.
CLINICAL MICROBIOLOGY REVIEWS (2021)
Characterization of NDM-1-Producing Carbapenemase in Proteus mirabilis among Broilers in China
Xiaolin Zhu et al.
MICROORGANISMS (2021)
Activity of meropenem/vaborbactam and comparators against Gram-negative isolates from Eastern and Western European patients hospitalized with pneumonia including ventilator-associated pneumonia (2014-19)
Dee Shortridge et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates
Mariana Castanheira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Antibiotic Resistance Pattern of Extended Spectrum Beta Lactamase Producing Escherichia coli Isolated From Patients With Urinary Tract Infection in Morocco
Mohamed Kettani Halabi et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Co-Existence of Certain ESBLs, MBLs and Plasmid Mediated Quinolone Resistance Genes among MDR E. coli Isolated from Different Clinical Specimens in Egypt
Salwa Mahmoud Masoud et al.
ANTIBIOTICS-BASEL (2021)
Detection of Multidrug-Resistant Enterobacterales-From ESBLs to Carbapenemases
Janina Noster et al.
ANTIBIOTICS-BASEL (2021)
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Mariana Castanheira et al.
JAC-ANTIMICROBIAL RESISTANCE (2021)
Outbreak of Efficiently Transferred Carbapenem-Resistant blaNDM-Producing Gram-Negative Bacilli Isolated from Neonatal Intensive Care Unit of an Indian Hospital
Shamsi Khalid et al.
MICROBIAL DRUG RESISTANCE (2020)
Changing Characteristics and In Vitro Susceptibility to Ceftazidime/Avibactam of Bloodstream Extensively Drug-Resistant Klebsiella pneumoniae from a Greek Intensive Care Unit
Angeliki Mavroidi et al.
MICROBIAL DRUG RESISTANCE (2020)
In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016)
James A. Karlowsky et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections
Adam G. Stewart et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-ResistantEnterobacteriaceaeIsolated From Adult and Children Patients in China
Renru Han et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Carbapenem-Sparing Strategies for ESBL Producers: When and How
Ilias Karaiskos et al.
ANTIBIOTICS-BASEL (2020)
Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
Chau-Chyun Sheu et al.
FRONTIERS IN MICROBIOLOGY (2019)
Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
Basem M. Alraddadi et al.
BMC INFECTIOUS DISEASES (2019)
Prevalence of extended-spectrum beta-lactamase producing bacteria from animal origin: A systematic review and meta-analysis report from India
Suresh P. Kuralayanapalya et al.
PLOS ONE (2019)
Carbapenem-Resistant Enterobacteriaceae Posing a Dilemma in Effective Healthcare Delivery
Angus Nnamdi Oli et al.
ANTIBIOTICS-BASEL (2019)
Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
Sohita Dhillon
DRUGS (2018)
Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
Shio-Shin Jean et al.
FRONTIERS IN MICROBIOLOGY (2018)
The global epidemiology of carbapenemase-producing Enterobacteriaceae
David van Duin et al.
VIRULENCE (2017)
Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate
Anna Both et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world
Yohei Doi et al.
JOURNAL OF TRAVEL MEDICINE (2017)
Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
Deanna J. Buehrle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Boronic acid disk diffusion for the phenotypic detection of polymerase chain reaction-confirmed, carbapenem-resistant, gram-negative bacilli isolates
Rasha Elsherif et al.
BMC MICROBIOLOGY (2016)
The rapid spread of carbapenem-resistant Enterobacteriaceae
Robert F. Potter et al.
DRUG RESISTANCE UPDATES (2016)
Dissemination of the blaKPC gene by clonal spread and horizontal gene transfer: comparative study of incidence and molecular mechanisms
Amos Adler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Epidemiological Expansion, Structural Studies, and Clinical Challenges of New beta-Lactamases from Gram-Negative Bacteria
Karen Bush et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 65 (2011)
Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism
Amos Adler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)